Abstract
The present experimental study was planned to evaluate the effect of intrathecal administration of L-glutamic acid upon antinociception produced by intrathecal morphine in a prospective-controlled manner in conscious freely mobile Sprague-Dawley albino rats. After chronic catheterization of the spinal subarachnoid space, rats were randomly allocated into 12 treatment groups of ten each and the same number of rats served as saline control for the comparison. L-glutamic acid (100 mmol), morphine (1.2 mmol), ketamine (50 mmol) and saline (150 mmol) were injected intrathecally in 5 microliters volumes. Naloxone was injected in a dose of 1 mg.kg-1 im. Immediately before and 15, 30 min, 1, 2 and 3 hr after injection, rats were subjected to a thermal noxious stimulus, using a tail-flick technoanalgesiometer and tail-flick latencies (TFL) were recorded. Intrathecal administration of L-glutamic acid attenuated the antinociceptive effect of intrathecal morphine with a decrease in TFL (1.4 +/- 0.3 sec; P < 0.0001) from 6.6 +/- 0.3 sec. Ketamine led to abolition of this effect (P < 0.01). In rats, pretreated with naloxone, there was restoration as well as augmentation of morphine-induced antinociception in the presence of L-glutamic acid with an increase in TFL (9.0 +/- 0.4 sec; P < 0.0001). We conclude that there is modulation of opioid receptors by L-glutamic acid at the spinal site in rats.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.